Evidence map›Paper›PMID 37901041›Full record

ArticleBrain communications2023

A blunted T

Adam D Bachstetter, Jenny Lutshumba, Edric Winford, Erin L Abner, Barbra J Martin, Jordan P Harp, Linda J Van Eldik, Frederick A Schmitt, Donna M Wilcock, Ann M Stowe and 2 more

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Adam D BachstetterSpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA.ORCID https://orcid.org/0000-0003-4646-6757
Jenny LutshumbaSpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA.
Edric WinfordDepartment of Neuroscience, University of Kentucky, Lexington, KY 40536, USA.
Erin L AbnerSanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA.
Barbra J MartinSanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA.
Jordan P HarpSanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA.
Linda J Van EldikDepartment of Neuroscience, University of Kentucky, Lexington, KY 40536, USA.
Frederick A SchmittSpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA.
Donna M WilcockDepartment of Neuroscience, University of Kentucky, Lexington, KY 40536, USA.
Ann M StoweDepartment of Neuroscience, University of Kentucky, Lexington, KY 40536, USA.
Gregory A JichaSanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA.
Barbara S NikolajczykDepartment of Pharmacology and Nutritional Science, and Barnstable Brown Diabetes and Obesity Center, University of Kentucky, Lexington, KY 40536, USA.
University of Kentucky · US

Funding

University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
The University of Kentucky MarkVCID Biomarker Validation Cohort: Development of a Toolbox to Advance VCID Interventional StudiesUF1NS125488 · NINDS · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, WILCOCK, DONNA M · 2021 to 2023
$6.1M
Pilot Projects ProgramP30GM127211 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2018 to 2022
$5.7M
Training in Translational Research in Alzheimer's and Related Dementias (TRIAD)T32AG057461 · NIA · UNIVERSITY OF KENTUCKY · PI MURPHY, MICHAEL PAUL, VAN ELDIK, LINDA J · 2017 to 2021
$2.1M
Biomarkers to track effective interventions that delay dementia onset in participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" trialR56AG074613 · NIA · UNIVERSITY OF KENTUCKY · PI GERMAN, DWIGHT C., STOWE, ANN MARIE · 2021 to 2021
$715k
Pumping iron: Loss of iron homeostasis causes microglia degeneration in ADR21AG066865 · NIA · UNIVERSITY OF KENTUCKY · PI BACHSTETTER, ADAM D · 2020 to 2020
$421k
The Biological Mechanisms of Metformin Effects on Aging-Associated InflammationR56AG069685 · NIA · UNIVERSITY OF KENTUCKY · PI NIKOLAJCZYK, BARBARA · 2020 to 2020
$380k
NIA NIH HHS P30 AG072946NIA NIH HHS R21 AG066865NIA NIH HHS R56 AG069685NIA NIH HHS R56 AG074613NIA NIH HHS T32 AG057461NIGMS NIH HHS P30 GM127211NINDS NIH HHS UF1 NS125488
6 · The paper itself

Abstract

People with dementia have an increase in brain inflammation, caused in part by innate and adaptive immune cells. However, it remains unknown whether dementia-associated diseases alter neuro-immune reflex arcs to impact the systemic immune system. We examined peripheral immune cells from a community-based cohort of older adults to test if systemic inflammatory cytokine signatures associated with early stages of cognitive impairment. Human peripheral blood mononuclear cells were cultured with monocyte or T-cell-targeted stimuli, and multiplex assays quantitated cytokines in the conditioned media. Following T-cell-targeted stimulation, cells from women with cognitive impairment produced lower amounts of T

Indexed as

Alzheimer’s diseasebiomarkerimmunityneuroimmunologysex differences

Identifiers

PMID37901041
PMCPMC10612408
OpenAlexW4387422513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.